Literature DB >> 26655242

PhiXing-it, displaying foreign peptides on bacteriophage ΦX174.

Kristofer J Christakos1, Janice A Chapman2, Bentley A Fane3, Samuel K Campos4.   

Abstract

Although bacteriophage φX174 is easy to propagate and genetically tractable, it is use as a peptide display platform has not been explored. One region within the φX174 major spike protein G tolerated 13 of 16 assayed insertions, ranging from 10 to 75 amino acids. The recombinant proteins were functional and incorporated into infectious virions. In the folded protein, the peptides would be icosahedrally displayed within loops that extend from the protein׳s β-barrel core. The well-honed genetics of φX174 allowed permissive insertions to be quickly identified by the cellular phenotypes associated with cloned gene expression. The cloned genes were easily transferred from plasmids to phage genomes via recombination rescue. Direct ELISA validated several recombinant virions for epitope display. Some insertions conferred a temperature-sensitive (ts) protein folding defect, which was suppressed by global suppressors in protein G, located too far away from the insertion to directly alter peptide display. Published by Elsevier Inc.

Entities:  

Keywords:  Antigen display; HPV; HPV16; L2; Microvirus; Papillomavirus; Peptide display; Phage display; RG-1; ΦX174

Mesh:

Substances:

Year:  2015        PMID: 26655242      PMCID: PMC6191337          DOI: 10.1016/j.virol.2015.11.021

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  48 in total

1.  RNA bacteriophage capsid-mediated drug delivery and epitope presentation.

Authors:  William L Brown; Robert A Mastico; Min Wu; Karen G Heal; Chris J Adams; James B Murray; Jeremy C Simpson; J Michael Lord; Andrew W Taylor-Robinson; Peter G Stockley
Journal:  Intervirology       Date:  2002       Impact factor: 1.763

2.  Icosahedral bacteriophage ΦX174 forms a tail for DNA transport during infection.

Authors:  Lei Sun; Lindsey N Young; Xinzheng Zhang; Sergei P Boudko; Andrei Fokine; Erica Zbornik; Aaron P Roznowski; Ian J Molineux; Michael G Rossmann; Bentley A Fane
Journal:  Nature       Date:  2013-12-15       Impact factor: 49.962

3.  Phage T4 SOC and HOC display of biologically active, full-length proteins on the viral capsid.

Authors:  Z Ren; L W Black
Journal:  Gene       Date:  1998-07-30       Impact factor: 3.688

4.  Structure of a viral procapsid with molecular scaffolding.

Authors:  T Dokland; R McKenna; L L Ilag; B R Bowman; N L Incardona; B A Fane; M G Rossmann
Journal:  Nature       Date:  1997-09-18       Impact factor: 49.962

5.  Multicomponent anthrax toxin display and delivery using bacteriophage T4.

Authors:  Sathish B Shivachandra; Qin Li; Kristina K Peachman; Gary R Matyas; Stephen H Leppla; Carl R Alving; Mangala Rao; Venigalla B Rao
Journal:  Vaccine       Date:  2006-10-17       Impact factor: 3.641

6.  Scaffolding proteins altered in the ability to perform a conformational switch confer dominant lethal assembly defects.

Authors:  James E Cherwa; Asako Uchiyama; Bentley A Fane
Journal:  J Virol       Date:  2008-04-09       Impact factor: 5.103

7.  Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2.

Authors:  Hannah H Alphs; Ratish Gambhira; Balasubramanyam Karanam; Jeffrey N Roberts; Subhashini Jagu; John T Schiller; Weiguang Zeng; David C Jackson; Richard B S Roden
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-14       Impact factor: 11.205

8.  Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines.

Authors:  Subhashini Jagu; Balasubramanyam Karanam; Ratish Gambhira; Sudha V Chivukula; Revathi J Chaganti; Douglas R Lowy; John T Schiller; Richard B S Roden
Journal:  J Natl Cancer Inst       Date:  2009-05-26       Impact factor: 13.506

9.  Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach.

Authors:  Wai-Hong Wu; Tanwee Alkutkar; Balasubramanyan Karanam; Richard B S Roden; Gary Ketner; Okechukwu A Ibeanu
Journal:  Virol J       Date:  2015-09-11       Impact factor: 4.099

10.  Diagnostic Immunization with Bacteriophage ΦX 174 in Patients with Common Variable Immunodeficiency/Hypogammaglobulinemia.

Authors:  Lauren L Smith; Rebecca Buckley; Patricia Lugar
Journal:  Front Immunol       Date:  2014-08-29       Impact factor: 7.561

View more
  2 in total

1.  Finally, a Role Befitting Astar: Strongly Conserved, Unessential Microvirus A* Proteins Ensure the Product Fidelity of Packaging Reactions.

Authors:  Aaron P Roznowski; Sarah M Doore; Sundance Z Kemp; Bentley A Fane
Journal:  J Virol       Date:  2020-01-06       Impact factor: 5.103

2.  Furin Cleavage of L2 during Papillomavirus Infection: Minimal Dependence on Cyclophilins.

Authors:  Matthew P Bronnimann; Christine M Calton; Samantha F Chiquette; Shuaizhi Li; Mingfeng Lu; Janice A Chapman; Kristin N Bratton; Angela M Schlegel; Samuel K Campos
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.